"I'd like patients to know that my team and I focus all of our efforts on developing innovative treatments for our patients. That is what drives us every day. The knowledge that we are getting continuously closer to curing cancer," says our Dr. Katy Rezvani. Watch here to learn how she and her team work to tailor treatment to each patient. #CancerResearch #EndCancer
MD Anderson Cancer Center
Hospitals and Health Care
Houston, TX 228,609 followers
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Our mission: #EndCancer
About us
The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention. MD Anderson provides cancer care at several convenient locations throughout the Greater Houston Area and collaborates with community hospitals and health systems nationwide through MD Anderson Cancer Network®. U.S. News & World Report's "Best Hospitals" survey has ranked MD Anderson the nation's top hospital for cancer care. Every year since the survey began in 1990, MD Anderson has been named one of the top two cancer hospitals. The recognition reflects the passion of our 21,000 extraordinary employees and 1,000 volunteers for providing exceptional care to our patients and their families, and for realizing our mission to #EndCancer. You can view all of our career opportunities at careers.mdanderson.org.
- Website
-
http://MDAnderson.org
External link for MD Anderson Cancer Center
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Houston, TX
- Type
- Educational
- Founded
- 1944
- Specialties
- Cancer, hospital, healthcare, oncology, research, doctor, health, wellness, medicine, education, education, science, health, clinical trials, nursing, cancer care, cancer research, training, fellowship, cancer education, cancer prevention, cancer treatment, and science and technology
Locations
Employees at MD Anderson Cancer Center
-
Guy Lipof
Data Science, AI, Executive, Healthcare & Life Sciences
-
Opral Wisham
QA Analyst V at Devon Energy
-
Ferran Prat Escude
Senior VP, Research Administration and Industry Relations at MD Anderson Cancer Center
-
Jake Lowry
Associate Professor of Comparative Medicine/Veterinarian at The University of Texas MD Anderson Cancer Center
Updates
-
"We really want to make sure that patients fully understand and feel free to ask any and every question they have so that they're empowered to make the best decisions and allow us to be part of that journey," says our Dr. Van Morris. Here, he discusses treating rare cancers and what makes MD Anderson special. #EndCancer
-
New research from MD Anderson includes: - Modified drug reverses chronic pain - Trial Insights for myelodysplastic syndromes - Targeting microRNAs in chronic lymphocytic leukemia - Chemotherapy before surgery for head and neck cancers - Models for biliary tract cancers Learn more. #CancerResearch #EndCancer
-
Our Angela Harris never expected to face four different cancer diagnoses in only two years. But thanks to treatment at MD Anderson, she's both a proud employee and a survivor. Read her story. #HealthCare #EndCancer
4-time cancer survivor and employee: Why I chose MD Anderson for my treatment
mdanderson.org
-
MD Anderson was awarded nearly $8 million today from the Cancer Prevention and Research Institute of Texas to boost faculty recruitment and cancer screening programs. This funding supports our mission to end cancer by advancing critical early detection and prevention efforts across Texas. Learn more. #CancerResearch #EndCancer
MD Anderson receives nearly $8 million in CPRIT funding for screening and early detection programs, faculty recruitment
mdanderson.org
-
A recent study led by MD Anderson's Dr. Nicholas Navin reveals breast tissue in healthy women contains cells that resemble breast cancer. "This has pretty big implications not just for the field of breast cancer, but potentially for multiple cancer types," says Navin. Learn more about what this could mean for early detection. https://bit.ly/4i06pr2 #CancerResearch #EndCancer
Healthy women have cells that resemble breast cancer, study finds
mdanderson.org
-
The FDA has approved revumenib for some patients with relapsed or refractory acute leukemia. MD Anderson played an important role in testing this drug through clinical trials. "Our research confirmed the significant benefits and efficacy of this therapy for both adult and pediatric patients," says our Dr. Ghayas Issa. Learn more: https://bit.ly/40Rpe9M #EndCancer
-
-
Last night, we honored employees with 25+ years of service. Congratulations to all of the honorees! And thank you for all that you to do help us #EndCancer.
-
-
Congratulations, Dr. Giulio Draetta! Thank you for everything you do to further our mission to #EndCancer. #CancerResearch
Humbled and honored to have received the 2024 American Italian Cancer Foundation Prize for Scientific Excellence in Medicine along with Dr. Laura Esserman. Previous winners include many of our friends, among those our beloved John Mendelsohn, Jim Allison, Ron DePinho, David Livingston, Nancy Davidson, Gigi Lozano. Grateful to colleagues who nominated me and to the Foundation leaders.
-
-
MD Anderson researchers are breaking new ground in immunotherapy. Dr. Jianjun Jay Zhang, Dr. Elise Nassif Haddad and Dr. Adam Grippin share how they're thinking outside the box to transform treatment. Learn more. #CancerResearch #EndCancer
Innovative directions in immunotherapy research
mdanderson.org